Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


European Science Foundation Sets Out Research Strategy ...

... to Push Rheumatic Diseases up the Health Agenda and Speed Development of New Therapies

Europe's Experts in the Field Will Hear the Plan and Discuss the Recommendations at Their Annual Meeting in Amsterdam this Week.

The world's largest meeting of experts in rheumatic diseases will today hear and debate calls for a pan-European approach to prioritise and combine the efforts of many excellent scientific and clinical groups working at a national level, and accelerate research in the field.

The European League Against Rheumatism (EULAR) meeting in Amsterdam will be briefed on the findings of an expert group on rheumatic diseases, established by the ESF to set out research priorities for Europe, to improve treatments and prevent disease.

Stiff and aching joints may be accepted as an inevitable aspect of ageing, but the fact is that rheumatism is the leading cause of pain and disability in Europe, with approximately 100 million sufferers. Joint diseases account for half of all chronic conditions in over 65-year olds, a figure that will rise as the population ages.

And while these diseases are mainly afflictions of age, there is significant unmet medical need in paediatric rheumatism.

The cost of treatments and the economic loss caused by rheumatic diseases is estimated to more than Euros 200 billions per year.

The task force, comprising Europe's leading researchers and clinicians, along with observers from a patients' representative group and the European Medicines Agency, EMEA, has looked across the field, considering all aspects of basic research and clinical practice, and distilled its findings into five key recommendations. The aim is to provide coherent objectives for national and European funding bodies and healthcare providers, and ensure that rheumatic diseases are acknowledged as a major group of diseases within the European Commission Framework Programme 7.

Bertil Andersson, ESF Chief Executive said, "The ambition in this policy paper lies not only in identifying key issues in epidemiology, basic, translational and public health research in rheumatic diseases, but also in presenting the considered and balanced view of experts from across the field on what the research priorities should be."

The following recommendations are made:

The ESF and EULAR want scientists meeting in Amsterdam this week to discuss and question these recommendations, enabling them to be refined and presented as representing the views of all Europe's experts in rheumatic diseases.

Professor Maxime Dougados of Groupe Hospitalier Cochin, Paris, co-chair of the task force group said, "Excellent research is being carried out in countries across Europe. We need to create bridges to allow data be pooled so we can compare or merge different cohorts. This will help us to assess the burden of disease, understand the predisposing factors and find biomarkers for diagnosing and monitoring disease."

"At the same time we need a strong relationship between EMEA and rheumatologists, to allow patients' needs to be considered in the drug approval process, and to ensure the regulator gets consistent, independent and expert advice."

Co-chair, Professor Andreas Radbruch of DRFZ, Berlin, said, "The great challenge in rheumatology today is to apply the growing understanding of the underlying molecular mechanisms - both in terms of how disease is initiated and propagated, and the cellular processes involved in degeneration and regeneration of the affected tissues - to develop disease-modifying and regenerative therapies."

"Across Europe, there is considerable competence in the field of rheumatology, but it will require significant pan-European coordination and funding of integrated research to achieve this goal."

Dr Carole Moquin-Pattey
Professor Maxime Dougados
Professor Andreas Radbruch

Dr Carole Moquin-Pattey | presseportal
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>